FKBP, the binding protein for the immunosuppressive drug, FK-506, is not an inhibitor of protein kinase C activity
- 31 October 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 180 (2) , 846-852
- https://doi.org/10.1016/s0006-291x(05)81142-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Relationship of FKBP to PKCI-2Nature, 1991
- FK506 and protein kinase CNature, 1991
- The peptidyl-prolyl isomerase, FK506-binding protein, is most likely the 12 kd endogenous inhibitor 2 of protein kinase CCell, 1991
- Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?The Journal of Experimental Medicine, 1991
- Rapamycin and FK506 binding proteins (immunophilins)Journal of the American Chemical Society, 1991
- Amino acid sequence of a 12‐kDa inhibitor of protein kinase CEuropean Journal of Biochemistry, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteinsNature, 1989
- Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilinNature, 1989
- PROTEIN KINASE ACTIVATION AND THE IMMUNOSUPPESSANT CYCLOSPORINETransplantation, 1986